Profile data is unavailable for this security.
About the company
Boiron SA is a France-based pharmaceutical company engaged in the provision of homeopathic medicines. The Company develops, manufactures and markets single homeopathic medicines and drugs which are in the form of tablets, syrups, single-dose liquids and ointments. It also produces medicines based on trace elements, phytotherapy remedies, food supplements, as well as health and beauty care products. In addition, the Company owns a research center, which works for the development of homeopathy within the world of medicine. Boiron SA operates through a number of subsidiaries, which are based in Italy, Spain, Belgium, the Czech Republic, Slovakia, Russia, Romania, Poland, Hungary, the United States, Canada and Brazil, among others.
- Revenue in EUR (TTM)481.71m
- Net income in EUR23.69m
- Incorporated1967
- Employees2.79k
- LocationBoiron SA2 avenue de l ouest LyonnaisRONTALON 69510FranceFRA
- Phone+33 478456100
- Fax+33 478456291
- Websitehttps://www.boiron.fr/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ScinoPharm Taiwan Ltd | 99.94m | 11.75m | 537.11m | 1.01k | 45.83 | 1.78 | 21.07 | 5.37 | 0.5084 | 0.5084 | 4.33 | 13.12 | 0.2871 | 1.27 | 6.63 | -- | 3.37 | 2.33 | 3.69 | 2.51 | 38.89 | 41.09 | 11.76 | 9.10 | 5.00 | -- | 0.0592 | 109.25 | -2.39 | -2.00 | -18.73 | -8.31 | 16.90 | -9.35 |
| Obio Technology Shanghai Corp Ltd | 32.97m | -32.31m | 537.75m | 731.00 | -- | 2.20 | -- | 16.31 | -0.3834 | -0.3834 | 0.3915 | 2.89 | 0.1012 | 4.00 | 2.55 | 344,293.00 | -9.93 | 0.2246 | -11.17 | 0.2514 | -26.42 | 36.72 | -98.16 | 1.48 | 2.27 | -- | 0.104 | 0.00 | -29.69 | 35.88 | -425.90 | -- | 57.00 | -- |
| SeQuent Scientific Ltd | 159.98m | 615.26k | 547.78m | 1.20k | 916.97 | -- | 62.89 | 3.42 | 0.2137 | 0.2137 | 57.18 | -- | -- | -- | -- | 11,939,190.00 | -- | 1.09 | -- | 1.76 | 45.38 | 41.97 | 0.9902 | 1.18 | -- | 0.9009 | -- | 35.06 | -3.60 | 5.68 | 70.40 | -- | 6.96 | -- |
| Jiangsu Aidea Pharmaceutical Co Ltd | 53.54m | -13.70m | 547.95m | 476.00 | -- | 3.91 | -- | 10.23 | -0.2384 | -0.2384 | 0.9459 | 2.54 | 0.2193 | 0.9553 | 2.66 | 858,576.30 | -5.65 | -2.40 | -8.32 | -2.85 | 48.96 | 39.00 | -25.77 | -10.15 | 1.11 | -- | 0.3018 | -- | 68.44 | 8.24 | 38.75 | -- | -4.47 | -- |
| Supriya Lifescience Ltd | 70.08m | 17.66m | 549.50m | 448.00 | 31.16 | 5.41 | 28.04 | 7.84 | 19.54 | 19.54 | 77.55 | 112.56 | 0.6737 | 2.01 | 6.56 | 13,950,510.00 | 16.98 | 19.08 | 18.38 | 24.04 | 66.81 | 57.12 | 25.20 | 24.71 | 4.05 | 111.46 | 0.006 | 2.88 | 23.74 | 15.47 | 32.56 | 24.75 | 83.79 | -- |
| Pharmanutra SpA | 106.64m | 14.50m | 551.82m | 112.00 | 37.79 | 9.99 | 31.17 | 5.17 | 1.51 | 1.51 | 11.09 | 5.70 | 0.9827 | 0.6257 | 4.40 | 1,015,648.00 | 13.36 | 18.39 | 17.76 | 24.80 | 95.63 | 96.36 | 13.59 | 17.77 | 1.84 | 41.91 | 0.3305 | 52.51 | 21.13 | 16.51 | -14.73 | 8.44 | 75.71 | 11.20 |
| Zhejiang Starry Pharmaceutical Co Ltd | 310.44m | 1.82m | 551.96m | 1.85k | 191.36 | 1.58 | -- | 1.78 | 0.0502 | 0.0502 | 5.72 | 6.08 | 0.4094 | 1.74 | 6.76 | 1,284,337.00 | 0.2471 | 3.30 | 0.4806 | 5.97 | 21.35 | 32.35 | 0.6036 | 8.21 | 0.4855 | 1.21 | 0.4994 | 53.08 | 3.04 | 19.78 | 158.32 | -13.94 | 10.39 | -- |
| Adcock Ingram Holdings Limited | 500.64m | 42.26m | 553.53m | 2.44k | 12.57 | 1.61 | -- | 1.11 | 5.26 | 5.26 | 62.36 | 40.94 | 1.16 | 2.57 | 4.50 | 3,958,591.00 | 9.80 | 10.24 | 13.97 | 14.44 | 33.38 | 30.34 | 8.44 | 9.05 | 0.9267 | -- | 0.0493 | 41.41 | 5.60 | 6.38 | -9.39 | 3.37 | -9.93 | 6.58 |
| Boiron SA | 481.71m | 23.69m | 555.31m | 2.79k | 23.20 | 1.47 | 13.12 | 1.15 | 1.36 | 1.36 | 27.74 | 21.48 | 0.7352 | 1.29 | 6.19 | 171,427.80 | 3.42 | 4.59 | 4.21 | 5.76 | 72.84 | 74.02 | 4.65 | 6.80 | 1.37 | -- | 0.0383 | 53.86 | -7.67 | -3.98 | -19.80 | -9.01 | -17.68 | -1.42 |
| ASP Isotopes Inc | 2.17m | -25.60m | 561.14m | 76.00 | -- | 39.44 | -- | 258.22 | -0.628 | -0.628 | 0.0549 | 0.2112 | 0.068 | -- | -- | 30,206.32 | -71.81 | -- | -89.44 | -- | 36.54 | -- | -1,055.85 | -- | -- | -8.11 | 0.6748 | -- | -- | -- | -229.34 | -- | -- | -- |
| Shandong Boan Biotechnology Co Ltd | 94.19m | 8.09m | 570.52m | 777.00 | 67.03 | 2.98 | 33.25 | 6.06 | 0.1305 | 0.1305 | 1.52 | 2.94 | 0.3069 | 1.10 | 2.60 | 952,245.10 | 2.63 | -- | 3.43 | -- | 74.10 | -- | 8.59 | -- | 1.03 | 4.01 | 0.3369 | -- | 19.80 | -- | 64.02 | -- | -- | -- |
Data as of Nov 14 2024. Currency figures normalised to Boiron SA's reporting currency: Euro EUR
4.66%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Financi�re de l'�chiquier SAas of 27 Mar 2024 | 238.57k | 1.36% |
| The Vanguard Group, Inc.as of 02 Oct 2024 | 126.50k | 0.72% |
| Dimensional Fund Advisors LPas of 03 Oct 2024 | 83.74k | 0.48% |
| DNCA Finance SAas of 31 Mar 2023 | 74.85k | 0.43% |
| HC Capital Advisors GmbHas of 30 Jun 2024 | 72.12k | 0.41% |
| HMG Finance SAas of 28 Mar 2024 | 70.95k | 0.40% |
| Sycomore Asset Management SAas of 31 Jul 2024 | 68.67k | 0.39% |
| Norges Bank Investment Managementas of 30 Jun 2024 | 47.88k | 0.27% |
| Chaussier Gestion SAas of 27 Sep 2024 | 19.00k | 0.11% |
| Montaigne Capital SASas of 30 Aug 2024 | 15.58k | 0.09% |
More ▼
Data from 30 Jun 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
